|
Overview
| Day 1
| Day 2
| Day 3
| Download
Brochure|
Breakout
Discussions
| Recommended Short Courses*
|
(SC3) REALITY CHECK ON COMPANION DIAGNOSTICS
(Click on the title to view the full
description)
|
|
9:00 am – 12:00 pm
This conference will cover the economics and standard practice for co-development of a drug with a diagnostic through the drug development process to the clinic.
Key topics to be addressed:
-
Utilizing novel technologies for personalized medicine
-
Improving molecular diagnostic assays to meet the standard of care, and adoption by clinical researchers
Course Instructors:
Jorge A. León, Ph.D., President, Leomics Consulting
Richard Bender, M.D., FACP, Chief Medical Officer, Agendia, Inc.
Bryan M. Dechairo, Ph.D, Senior Director, Development Head - Personalized Medicine R & D, Medco Health Solutions, Inc.
|
*Separate Registration Required |
Attend this premier event to …
-
Learn CRITERIA for a Practical Clinical BENEFIT from a Stratified Medicine Approach
-
TRANSFORM a Laboratory Biomarker to Clinically RELIABLE
Diagnostic Test
-
Discover the NEXT Wave of Assays for Personalized
Medicine
-
Implement NEW Integrated and Personalized Approaches to Diagnosis
-
Develop MODELS for Companion Diagnostics
-
STREAMLINE Translation of Biomarkers into Future
Companion Diagnostics
KEYNOTE SPEAKERS
 Daniel H. Farkas, Ph.D., HCLD, Executive Director, Center for
Molecular Medicine
 William J. Rutter, Ph.D., Chairman, Synergenics LLC
 Steve Shak, M.D., Chief Medical Officer,
Genomic Health Inc.
 John A. Todd, Ph.D., University Chair, Medical Genetics, University of Cambridge
Overview
| Day 1
| Day 2
| Day 3
| Download
Brochure|
Breakout
Discussions
For more information, please
contact Christina Lingham at:
Cambridge Healthtech Institute
250 First Avenue, Suite #300
Needham, MA 02494
Tel: 781-972-5464
Fax: 781-972-5425
email:
clingham@healthtech.com
Nicole Lewis
Marketing Manager
Cambridge Healthtech Institute
T: 781.972.5417
F: 781.972.5425
E: nlewis@healthtech.com
|
2009 Final
Brochure Download
|
